The Preparation of Capsaicin-Chitosan Microspheres (CCMS) Enteric Coated Tablets

被引:20
作者
Chen, Jian [1 ]
Huang, Gui-Dong [1 ]
Tan, Si-Rong [1 ]
Guo, Jiao [1 ]
Su, Zheng-Quan [1 ]
机构
[1] Guangdong Pharmaceut Univ, Key Res Ctr Liver Regulat Hyperlipemia SATCM, Class Lab Metab SATCM 3, Guangdong TCM Key Lab Metab Dis, Guangzhou 510006, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
capsaicin; microspheres; enteric coated tablets; HPLC; OBESITY; TRENDS;
D O I
10.3390/ijms141224305
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study aimed to research the preparation and content determination of capsaicin-chitosan microspheres (CCMS) enteric coated tablets. The core tablets were prepared with the method of wet granulation. Nine formulae were designed to determine the optimal formula of the core tablet. Eudragit L100 was used to prepare the CCMS enteric-coated tablets. The effect of enteric coated formulation variables such as content of talc (10%, 25% and 40%), plasticisers (TEC and DBS), dosage of plasticiser (10%, 20% and 30%) and coating weight (2%, 3% and 5%) were evaluated for drug release characteristics. The in vitro release was studied using 0.1 N HCl and pH 6.8 phosphate buffer. Enteric coated tablets without ruptures or swelling behaviour over 2 h in 0.1 N HCl indicated that these tablets showed acid resistance. The accumulated release rate in phosphate buffer (pH 6.8) revealed that the prepared tablets were able to sustain drug release into the intestine and a first-order release was obtained for capsaicin. This research is the first report of the preparation and content determination of CCMS enteric coated tablets. The sustained release behavior of enteric coated formulations in pH 6.8 phosphate buffer demonstrated that it would be a potential drug delivery platform for sustained delivery of gastric irritant drugs.
引用
收藏
页码:24305 / 24319
页数:15
相关论文
共 30 条
[1]   Digging deeper into obesity [J].
Ahima, Rexford S. .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (06) :2076-2079
[2]   Preventing childhood obesity: what works? [J].
Birch, L. L. ;
Ventura, A. K. .
INTERNATIONAL JOURNAL OF OBESITY, 2009, 33 :S74-S81
[3]   Chronic Diseases: Chronic Diseases and Development 3 Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness [J].
Cecchini, Michele ;
Sassi, Franco ;
Lauer, Jeremy A. ;
Lee, Yong Y. ;
Guajardo-Barron, Veronica ;
Chisholm, Daniel .
LANCET, 2010, 376 (9754) :1775-1784
[4]   Obesity: Person and population [J].
Cope, Mark B. ;
Allison, David B. .
OBESITY, 2006, 14 :156S-159S
[5]   Obesity, pancreatitis, and pancreatic cancer [J].
Gumbs, Andrew A. .
OBESITY SURGERY, 2008, 18 (09) :1183-1187
[6]   Chitosan Based Polyelectrolyte Complexes as Potential Carrier Materials in Drug Delivery Systems [J].
Hamman, Josias H. .
MARINE DRUGS, 2010, 8 (04) :1305-1322
[7]   Childhood obesity [J].
Han, Joan C. ;
Lawlor, Debbie A. ;
Kimm, Sue Y. S. .
LANCET, 2010, 375 (9727) :1737-1748
[8]   Obesity [J].
Haslam, DW ;
James, WPT .
LANCET, 2005, 366 (9492) :1197-1209
[9]   Overweight/obesity and cancer genesis: More than a biological link [J].
Irigaray, P. ;
Newby, J. A. ;
Lacomme, S. ;
Belpomme, D. .
BIOMEDICINE & PHARMACOTHERAPY, 2007, 61 (10) :665-678
[10]   Pathways to obesity [J].
Jéquier, E .
INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (Suppl 2) :S12-S17